Groundbreaking Osteoarthritis Therapies Could Enable Joint Regeneration and Eliminate Need for Surgery

New osteoarthritis therapies under development aim to help joints heal and regenerate rather than merely treat symptoms. A government agency has confirmed that several promising treatments are in advanced stages of research.

These innovative therapies focus on bone and cartilage regeneration and living knee implants, representing a potential breakthrough for the millions living with osteoarthritis. While further research is required to confirm safety and effectiveness in humans, the progress marks a significant shift in treatment approaches.

Osteoarthritis, the most common form of arthritis, primarily affects older adults and leads to varying degrees of pain and disability. It currently has no cure, and existing treatments focus on pain relief or joint replacement surgeries.

ARPA-H Launches NITRO Program to Revolutionize Osteoarthritis Treatment

A new initiative led by the Advanced Research Projects Agency for Health (ARPA-H) is set to transform osteoarthritis care. The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program is a collaboration between researchers from Duke University, Columbia University, and the University of Colorado Boulder.

The NITRO program aims to enable joints to heal themselves by regenerating bone and cartilage, potentially eliminating the need for joint replacement surgeries. Human trials are expected to begin within the next year, offering hope for the estimated 32 million Americans who live with osteoarthritis annually. The condition costs the U.S. healthcare system over $132 billion per year.

Three Key Approaches to Joint Regeneration

Osteoarthritis occurs when joint tissue is damaged due to aging, obesity, injury, overuse, congenital defects, or a family history of the disease. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, it can cause joint pain and stiffness, commonly affecting the hands, knees, hips, neck, and lower back.

The NITRO program focuses on three key approaches to joint regeneration:

• Bone regeneration
• Cartilage regeneration
• Development of living knee implants made from human tissue

Duke University’s Injectable Therapies

Researchers at Duke University have developed two injectable, time-released combination drug formulations designed to stimulate bone and cartilage regrowth in osteoarthritis-damaged joints. These therapies can be administered alone or together and are intended for infrequent use—only once per year—to relieve pain and restore joint function.

The team also created an intravenous time-release formulation to promote cartilage repair across multiple joints, reducing the need for multiple injections.

University of Colorado Boulder’s Rapid Repair Therapies

Researchers at the University of Colorado Boulder have contributed two therapies that enable aging or damaged joints to repair themselves rapidly in animal studies.

One therapy is a patented particle-delivery system injected into joints to deliver intermittent bursts of a repurposed regenerative drug over several months. The other is an engineered protein cocktail injected arthroscopically and allowed to harden in place for precise repair of cartilage lesions.

Columbia University’s Living Knee Implants

Researchers at Columbia University are engineering a living, 3D-printed human knee on a biodegradable scaffold infused with adult stem